ARTICLE | Financial News
Pharmadigm raises $12 million
May 2, 2000 7:00 AM UTC
Pharmadigm (Salt Lake City, Utah), an acute inflammation company, sold a series E venture round of convertible preferred stock to a group led by Friedli Corporate Finance, a Swiss venture capital firm...